Sorrento Presents Preliminary Results of STI-2020 Against COVID-19
Bora Pharmaceuticals to Acquire GSK’s Facility in Canada
¬Bora Pharmaceuticals to Acquire GSK’s Facility in Canada
Shots:
- Bora acquires GSK’s facility located in Mississauga, Ontario (Canada) which produces ~50 products and employs ~400 skilled manufacturing staff. The transaction is expected to be completed in H2’20
- As per the transaction, GSK’s staff will join the Bora which will continue to manufacture the existing GSK’s product line for a minimum of five years. The facility will move to a new location within a timeframe, following the closure of the transaction
- The acquisition will boost Bora’ technical capabilities & enables it to locally support its core markets of North America and Asia
Click here to read full press release/ article | Ref: Bora Pharmaceutical | Image: GSK